2016 Annual Meeting

Papanicolaou Society of Cytopathology

Room CC 602-604, March 12 2016, 7:00pm to 10:00pm


Papanicolaou Society of Cytopathology

Small Specimens vs. Big Questions in the Era of Precision Medicine and Cost Containment

Saturday, March 12, 2016
7:00 PM 10:00 PM
CC 602 604

Moderator: Zubair W. Baloch, MD, PhD, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

Course Description:
The PSC solicited topics of interest from their membership at the annual business meetings. Several potential topics were discussed at the Executive Board meeting and the topic for the 2016 session was chosen in agreement with the chairs of the scientific program committees. New approaches and challenges that pertain to the diagnosis of FNA and small tissue biopsies and related ancillary studies are of high interest to the PSC membership and are currently cited as an important topic in cytopathology.
Our needs assessment process was based on the evaluation of the current literature and the feedback by PSC members.
The following topic will be discussed: (1) Diagnosing Mesothelioma In Limited Tissue Samples, (2) Do’s And Don’ts Of Immunohistochemistry Of Limited Tissue Samples, (3) Update On Molecular Testing Of Cytology Samples, (4) Regulatory And Cost Containment Issues Affecting Molecular Diagnostic Laboratory. The first presenter will address various aspects of the diagnosis of malignant mesothelioma in small biopsy specimens; core and fine needle aspiration biopsy including diagnostic pitfalls and the incorporation of ancillary studies as an aid to the diagnosis of these challenging and controversial lesions. The second presentation will focus on employing immunohistochemistry studies in small biopsy specimen, including the use and abuse of various markers, judiciously using marker-panels and diagnostic pitfalls. The third presenter will provide an overview of what is new and exciting in the field of molecular testing on cytology specimens. This speaker will present their own institutional experience and how it measures against what is published in the literature. The final presentation will have a much broader appeal as the topic addresses the biggest challenge we face, that is to provide the best patient care possible in era of cost containment.


7:00 PM

Introduction of Program and Speakers
Zubair Baloch, MD, PhD, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

7:05 PM

PSC Awards Presentation
Tarik Elsheikh, MD, Cleveland Clinic, Cleveland, OH

7:20 PM

Diagnosing Mesothelioma in Limited Tissue Samples
Sanja Dacic, MD, PhD, University of Pittsburgh, PA

7:50 PM

Do’s and Don’ts of Immunohistochemistry of Limited Tissue Samples
Andrew Bellizzi, MD, University of Iowa Hospitals and Clinics, Iowa City, IA

8:20 PM

Update on Molecular Testing of Cytology Samples
Dara Aisner, MD, PhD, University of Colorado, Denver, CO

8:50 PM

Regulatory and Cost Containment Issues Affecting Molecular Diagnostic Laboratory- 10:0
Jennifer Hunt, MD, University of Arkansas for Medical Sciences, Little Rock, AR

9:20 PM

Discussion and Open Microphone Session


view more